Established in 2011, Teligene is a drug discovery company located in Suzhou BioBay, dedicating to developing innovative small-molecule drugs. We have a pipeline of candidate molecules with potential advantages over existing therapeutics that are aimed at improving patient outcomes in conditions with significant unmet medical need. Our mission: We are dedicating to design and develop novel small molecule drugs to improve quality of life. Our focus: We are concentrating our effects on cancer therapy, which is one of the areas of greatest unmet need. Our strength: We have embedded knowledge in key areas of the drug discovery process and utilize a highly sophisticated and effective combination of computational and structural approaches to drug design and optimization.